Skip to content
DraconiticResearch
Search Sources API
185,139 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY-NCCancer management and research

Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].

Read full textPDFDOICite

Abstract

[This retracts the article DOI: 10.2147/CMAR.S281969.].

Related

  1. Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
    Sijing Chen, Yunyang Zhao, Yunqi Pan +13
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. MYC Suppresses Mitochondrial Function in Hepatocellular Carcinoma through NRF1-Driven Receptor-Mediated Mitophagy
    N. P. Lesner, L. C. Kim, S. D. Shelton +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Apigenin suppresses ovarian cancer cell growth by disrupting TGF-beta1-mediated cancer–stroma interaction via AKT inhibition
    Youngjoo Kwon, Somin Lee, Hyunjin Seo +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Pharmacology & toxicologyCrossref
  4. Culture Dimensionality Shapes Drug Sensitivity to Kinase Inhibitor Combinations with Epigenetic or Metabolic Inhibition in a Hepatocellular Carcinoma Model
    Claudia Kunst, Tobias Schilling, Cedric Arling +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. LINC00907 suppresses malignant progression in hepatocellular carcinoma by inhibiting miR-24-3p.
    Jihua Cao, Weiyong Yang, Xiao Yang +1
    HereditasPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{anon2026inhibition,
  title = {{Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].}},
  journal = {Cancer management and research},
  year = {2026},
  month = oct,
  doi = {10.2147/cmar.s663555},
  url = {https://europepmc.org/article/MED/42936056},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].
PY  - 2026
DA  - 2026/10/21
JO  - Cancer management and research
DO  - 10.2147/cmar.s663555
UR  - https://europepmc.org/article/MED/42936056
AB  - [This retracts the article DOI: 10.2147/CMAR.S281969.].
SN  - 1179-1322
ER  -